Descubra el nuevo Chem-Impex: donde la innovación comienza con un vínculo.

Catalog Number:
41507
CAS Number:
291775-59-2
Ácido (1 R ,3 S ,4 S )- N -Boc-2-azabiciclo[2.2.1]heptano-3-carboxílico
Purity:
≥ 96,5 % (HPLC)
Synonym(s):
Ácido (1 R ,3 S ,4 S )-2-(terc-butoxicarbonil)-2-azabiciclo[2.2.1]heptano-3-carboxílico
Hazmat
Documents
$104.26 /250 mg
Tamaño
Request Bulk Quote
Información del producto

Adecuado para la síntesis de péptidos.

Número CAS
291775-59-2
Fórmula molecular
C12H19Nº 4
Peso molecular
0
Número MDL
MFCD11099876
Punto de fusión
147 - 152 °C
Rotación óptica
[ á]22/D = -170 ± 10° (C = 1 en Cloroformo)
Condiciones
Tienda en RT
Información general
Número CAS
291775-59-2
Fórmula molecular
C12H19Nº 4
Peso molecular
0
Número MDL
MFCD11099876
Punto de fusión
147 - 152 °C
Rotación óptica
[ á]22/D = -170 ± 10° (C = 1 en Cloroformo)
Condiciones
Tienda en RT
Propiedades
¡Pronto habrá más información sobre la propiedad!
-
Seguridad y normativas
Materiales peligrosos
-
Antibiótico
-
Regulado por la DEA
No
Advertencias
-
Aplicaciones

(1R,3S,4S)-N-Boc-2-azabicyclo[2.2.1]heptane-3-carboxylic acid is widely utilized in research focused on:

  • Synthetic Organic Chemistry: This compound serves as a versatile building block for synthesizing complex molecules, particularly in the development of pharmaceuticals and agrochemicals.
  • Drug Development: Its unique structure allows for the design of novel drug candidates, especially in the field of central nervous system disorders, enhancing the potential for effective treatments.
  • Peptide Synthesis: The compound is used in the preparation of peptide derivatives, which are crucial in creating biologically active compounds for therapeutic applications.
  • Chiral Catalysis: It plays a significant role in asymmetric synthesis, providing chiral centers that are essential for producing enantiomerically pure compounds, which are important in the pharmaceutical industry.
  • Research in Neuroscience: The compound's structural properties make it a candidate for studying receptor interactions, contributing to advancements in understanding neuropharmacology.

Citas